-29.15 (-1.78%) Credit rating agency, Crisil has assigned ‘A1+’ rating to Commercial Paper of Sun Pharmaceutical Industries. The rating agency has also reaffirmed ratings of ‘AAA/Stable’ and ‘A1+’ on the long term and short term bank facilities of the company, respectively.
Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.